|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.43/-0.97
|
企业价值
64.27M
|
资产负债 |
每股账面净值
-0.59
|
现金流量 |
现金流量率
--
|
损益表 |
收益
47.47M
|
每股收益
1.98
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/12 22:44 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring.Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. |